Antimicrobial Peptide Therapeutics for Cystic Fibrosis

Greater than 90% of lung infections in cystic fibrosis (CF) patients are caused by Pseudomonas aeruginosa, and the majority of these patients subsequently die from lung damage. Current therapies are either targeted at reducing obstruction, reducing inflammation, or reducing infection. To identify po...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhang, Lijuan, Parente, Jody, Harris, Scott M., Woods, Donald E., Hancock, Robert E. W., Falla, Timothy J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2005
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1168697/
https://ncbi.nlm.nih.gov/pubmed/15980369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.7.2921-2927.2005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados